One sentence summary: Engineered bacteria record an inflammatory response in an IBD mouse model and are genetically stable during long-term growth in the mouse gut.
3
The conversion of thiosulfate into tetrathionate downstream of ROS in the mouse intestine has been described during Salmonella typhimurium 12 and Yersinia enterocolitica 13 induced inflammation ( Figure S1 ). Tetrathionate, sensed through the TtrR/TtrS two-component system 14 , provides a growth advantage to these pathogens during inflammation 13, 15, 16 and may also be utilized by other microbes, particularly pathogens 17 . Elevated tetrathionate levels in toll-like receptor 1 deficient mice 13 and the enrichment of tetrathionate utilization genes in the microbiota of a Tbet -/-Rag -/mouse ulcerative colitis (TRUC) model 18 point to the molecule's potential as a more general marker of inflammation, including during IBD. However, as detection is not possible by non-invasive methods this has prohibited further investigation, particularly during human disease.
Here we engineer a tetrathionate-responsive commensal E. coli strain, NGF-1, based on our previous system for antibiotic detection and memory 5 . The system contains two parts: 1) the 'trigger', an environmentally-responsive promoter driving Cro protein expression ( Figure 1A , upper); and 2) the 'memory element', a Cro-inducible CI/Cro transcriptional switch derived from phage lambda 5 (Figure 1A , lower). Once memory is initiated, expression of a lacZ reporter gene allows memory-state quantification using indicator culture plates ( Figure 1A , lower). We utilized ttrR/S genes and the P ttrBCA promoter from S. typhimurium to drive Cro expression (Figure 2A , upper) creating strain PAS638 ( Figure 1A ; Table S1 ).
This engineered strain exhibits memory upon tetrathionate exposure. We induced memory under anaerobic liquid culture conditions to trigger P ttrBCA promoter expression in the presence of tetrathionate and quantified memory on aerobically grown plates in the absence of tetrathionate, which turned P ttrBCA expression off ( Figure 1B) . PAS638 bacteria showed a characteristic dose-response curve upon tetrathionate induction (EC50:0.38-0.85µM 95% CI) ( Figure 1C ). By comparison, the triggerless control strain, PAS637 (Table S1 ), showed no switching at 2mM tetrathionate ( Figure 1C ). Previous in vivo quantification did not detect tetrathionate in inflammation-free wild-type mice but showed concentrations in a low millimolar range under inflammatory conditions, suggesting the sensitivity of PAS638 is well adapted to physiologically relevant concentrations of the analyte 12, 13 .
PAS638 showed no tetrathionate response in two mouse strains and low-level response in a third, indicating the general absence of tetrathionate in healthy mice. For these baseline experiments we administered PAS638 to Balb/c, C57Bl/6 or 129X1/SvJ mice. We measured response through screening at least three serial fecal samples collected over the subsequent 5-8 days (Figure 2A ). Results showed no notable response of PAS638 in Balb/c or C57Bl/6 mice, but bacteria from a subset of 129X1/SvJ mice showed elevated switching ( Figure 2B ). We conclude PAS638 is not sensitive to background levels of tetrathionate in healthy Balb/c or C57Bl/6 mice. The elevated response in 129X1/SvJ mice was surprising, however, may result from known defects in macrophage recruitment to sites of inflammation in this strain 19, 20 . Based on this result, testing of the strains specificity for tetrathionate was undertaken in a C57Bl/6 background.
We tested the ability of PAS638 to detect inflammation during intestinal infection using murine S. typhimurium colitis as a model 21 . S. typhimurium strains that are tetrathionate reduction deficient cause elevated cecal tetrathionate, while strains with wild-type reduction capabilities do not 12 . To test the specificity of PAS638, we pretreated C57Bl/6 mice with streptomycin by oral gavage, and administered them PAS638, PAS638 with S. typhimurium, or PAS638 with a S. typhimurium ΔttrR variant which is unable to express tetrathionate reductase ( Figure 2C ; Table S1) 16 . We screened fecal samples collected on days 2-5 post-administration and observed no tetrathionate sensing in samples from control and S. typhimurium infected mice ( Figure 2D ). However, PAS638 co-administered with S. typhimurium ΔttrR showed elevated switching in a subset of mice ( Figure 2D ) with switching occurring on days 4-5 post-infection ( Figure   S2A ). Titers of PAS638 E. coli ( Figure S2B ) and S. typhimurium variants ( Figure S2C) were consistent between groups, demonstrating that variability in colonization was not responsible for the differences observed.
We also evaluated inflammation by lipocalin-2 (LCN-2) biomarker quantification ( Figure S2D Figure 2E ). The increasing rate of LCN-2 level rise at day 5 of the experiment suggests that longer-term monitoring of PAS638 switching would be ideal, however, this was not possible in the model due to susceptibility of C57Bl/6 mice to systemic salmonellosis. Nevertheless, these results demonstrate that our engineered memory strain 6 specifically senses the presence of tetrathionate and that tetrathionate sensing generally corresponds to a more acute inflammatory response in vivo.
Increased ROS levels are associated with IBD 23 . Interleukin-10 deficient mice (IL10 -/-) share characteristics with human IBD, including influence of the microbiota composition on disease progression 24 . To test the ability of PAS638 to detect subclinical inflammation in an IBD context, we colonized ~6 month-old, retired-breeder IL10 -/mice that were not expected to have active colitis (due to being raised in gnotobiotic and barrier SPF conditions) with PAS638 E. coli ( Figure 3A ). PAS638 bacteria measured on at least 3 separate days over a >2-week period showed elevated tetrathionate sensing in IL10 -/mice, but not separately-reared retired C57Bl/6 breeder controls ( Figure 3B ).
Switching levels in IL10 -/mice were measured >1-week following bacterial administration to rule out inflammation caused by the process of administration, which included treatment with streptomycin -a known inflammatory enhancer in other colitis models 25 . Indeed, fecal LCN-2 levels confirmed that inflammation in these mice was significantly elevated compared to controls in the week following bacterial administration but not subsequent to this when PAS638 switching was detected ( Figure 3C ). Furthermore, these LCN-2 values were low compared to levels associated with colitic IL10 -/mice 22 . We conclude that ROS and tetrathionate are elevated in the IL10 -/-IBD model and that our engineered bacteria can sense this in a physiologically relevant subclinical inflammatory environment.
PAS638 maintains robust function over periods of at least 6-months colonizing the mammalian gut. An overarching issue in synthetic biology is that non-native genetic circuits may cause in vivo fitness costs resulting in mutation, loss-of-function and selective elimination from the host. To test genetic and functional stability we used the PAS638-inducing environment of 129X1/SvJ mice to maintain ON and OFF memory, thus testing fitness costs associated with both states. We administered PAS638 to mice and screened fecal samples for sensing at selected time-points over the following 200 days, > 1600 bacterial generations 26 (Figure 4A ). PAS638 remained colonized at readily detectable titers throughout the experiment without further antibiotic selection ( Figure   4B ). As we observed previously ( Figure 2B ), tetrathionate levels as measured by PAS638 were variable in the 129X1/SvJ mice ( Figure 4C ). Consistent with the ability of PAS638 to detect inflammation, the presence of memory-ON state PAS638 bacteria broadly correlated with elevated LCN-2 levels, despite absolute LCN-2 levels being orders of magnitude lower than those measured during Salmonella infection ( Figure S2D ; Table   S2 ). Furthermore, while it was not possible to quantify any overall inflammation by histology, an inflamed Peyer's patch was observed from mouse 4 (data not shown).
Remarkably, colonies tested from fecal samples of mice at day 159 ( Figure 4D ) and day 200 (Table S3 ) retained the ability to respond to tetrathionate in vitro, indicating they had not acquired mutations to prevent their correct function.
Whole genome sequencing further demonstrated stability of these circuits. To analyze whether mutations had accrued in PAS638 during growth in the mammalian gut, mixtures of PAS638 colonies from each mouse at day 159 along with ancestral PAS638 were analyzed by whole genome sequencing. We sequenced to a depth capable of confidently identifying mutations greater than ~10% of the population (average chromosomal fold-coverage of 85-150). Only one unique mutation was identified from the five sequenced mixes (Table 1) . This repeat expansion in an intergenic region of the E. coli NGF-1 colicin-like plasmid was detected in 89% and 92% of reads from two of the five mice (Table 1) . Detection of a single mutant is consistent with the number expected from wild-type E. coli over >1200 generations 27, 28 . The two mice carrying bacteria with the detected mutations were housed together, while all other mice were separated at day 105 ( Figure 4A ). Given this mutation spread and fixed amongst the cohoused mice, we are confident that any beneficial mutations would have been detected at the sequencing depth we achieved. Together these findings indicate that these synthetic circuits place sufficiently low burden on the bacteria carrying them to allow robust function over >6-months in the complex gut environment.
Here we used engineered bacteria to track a marker of the mammalian inflammatory response that was previously not amenable to non-invasive monitoring.
Our results extend the previously limited knowledge of tetrathionate biology, confirming its association with inflammation in the presence and absence of pathogenic infection and specifically identifying its elevation in IL10 -/mice and 129X1/SvJ mice ( Figure 2B , 3B, Table S2 ). PAS638 proved sensitive to low-level inflammation in these models ( Figure   3B -C; Table S2 ) and in some cases provided more consistent results over a multiple day period than LCN-2 levels (Table S2) , possibly due to the memory capacity allowing signal integration over an extended period. The results point to a need for further research into this molecule, in particular whether it is similarly elevated in human inflammatory disease.
Several design features of this system stand out. The modularity of these circuits allows for inputs from any environmentally responsive promoter and outputs to any downstream gene circuit. Further, the self-regulating nature of the CI/Cro switch lowers 9 the burden of these circuits on host cells. Together this establishes a platform that can be expanded for the non-invasive monitoring of other transient species in the gut, as well as the potential for easy future integration into more complex on-demand synthetic circuits, such as sense-and-respond therapeutics.
Areas for future investigation and improvement to this system remain. In Taken together, our work dispels the view that all synthetic gene circuits would be subject to mutational loss-of-function under extended growth in the complex, competitive setting of the mammalian gut and demonstrates the ability for synthetic bacterial devices to make unique impacts on our understanding of disease.
Materials and Methods:
Strain construction:
Details of strains constructed for this study are provided (Table S1 ). All synthetic constructs were integrated chromosomally in the mouse commensal Escherichia coli NGF--1 strain 5 or Salmonella typhimurium 14028s.
The lambda derived CI/Cro memory element was originally inserted between the mhpR and lacZ loci of E. coli TB10 29 and transferred to E. coli NGF--1 by P1vir transduction 30 as previously described 5 S. typhimurium strains were derived from S. typhimurium 14028s. To confer tetracycline resistance to all S. typhimurium strains a zhj--1401::Tn10 construct from S. typhimurium LT2 SA2700 (Salmonella Genetic Stock Center) transferred to both S.
typhimurium strains used in this study by P22 transduction 31 . To prevent tetrathionate reduction capacity, a ttrR knock--out TT22470 16 construct was transferred to S. typhimurium by P22 transduction.
In vitro induction with tetrathionate: In vivo testing of tetrathionate memory:
The Harvard Medical School Animal Care and Use Committee approved all animal study protocols.
General analysis
For most experiments, female, Balb/c (Charles River), C57Bl/6 (Charles River) or 
Streptomycin treated Salmonella colitis model
The streptomycin--treated Salmonella colitis model was undertaken in C57Bl/6 mice (Charles River) as previously described 21 . Briefly, mice were administered with 20mg USP grade streptomycin sulfate (Gold Biotechnology) by oral gavage following 4h nil per os (NPO). 24 hours later, again following 4h NPO, mice were administered bacterial strains, resuspended from overnight culture in phosphate buffered saline (Gibco), by oral gavage. Bacteria were administered at 1x10 7 E. coli and 1x10 8 S.
typhimurium per mouse as previously described 21 Selective plating for enumeration of S. typhimurium strains was achieved on M9 + 0.4% glucose + 30μg/mL tetracycline (Sigma) agar. Enumeration and analysis of switching was achieved using plating on LB + 300μg/mL streptomycin sulfate (Sigma) + 60μg/mL x--gal (Santa Cruz Biosciences) agar.
IL10 knockout model
Male retired breeder mice (~6 months age) from an IL10 --/-background 32 were transferred to barrier SPF conditions, following growth under gnotobiotic conditions. The mice were colonized with a complex set of human commensal microbes, Gnotocomplex 2.0 (Table S4) , which is an expanded version of the Gnotocomplex designed to capture additional functionality and phylogenetic 14 diversity 33 . Control mice were male retired breeder mice (typically 6--8 months age) from a C57Bl/6 background raised in SPF conditions (Charles river). Mice were administered PAS638 bacteria (~3x10^7 per mouse) by oral gavage following USP streptomycin sulfate treatment (Gold Biotechnology; 0.5g/L in drinking water). In mice where colonization was lower than 2.5x10 4 CFU/g following gavage,
streptomycin was re--administered within the first week following bacterial administration for up to 48h to assist robust colonization.
Analysis of fecal samples was undertaken as described above. To avoid adverse influence of streptomycin and bacterial administration in IL10 --/---mice, which are sensitive to aberrant inflammatory responses (as evident from LCN--2 quantification in week 1 post administration ( Figure 4B) ), blue--white colony screening was not undertaken in the week following administration. Results were generated from 3--4 fecal samples taken over the subsequent 2 weeks for control C57Bl/6 mice and 1 month for IL10 --/-mice.
Whole Genome Sequencing and analysis:
Bacterial samples were selected by plating from feces, as described above, on LB + 300μg/mL streptomycin sulfate (Sigma) + 60μg/mL x--gal (Santa Cruz Biosciences) agar. Colonies were scraped from plates, resuspended and prepared for sequencing as a pool using a small--volume modification of the Illumina Nextera XP kit as described previously 34 gdtools package was used to modify the ancestral genbank file to eliminate mutations in the ancestral strain. We then ran breseq at high sensitivity (settings-consensus--minimum--coverage--each--strand 3 ----consensus--frequency--cutoff 0.1) to call mutations in the passaged strains.
Statistical analyses
All statistical analyses were undertaken in Prism 6 for Mac OS X (GraphPad). Details of individual tests and resulting p--values are included in figure legends and text where appropriate. Figure 1: Engineering and Figure   S2A ) when co-infected with S. typhimurium ΔttrR bacteria but not control or S. typhimurium wt bacteria. E) Cumulative LCN-2 levels in mice administered PAS638+ S.
Figures:
typhimurium ΔTtrR were higher in mice with PAS638 response (green lines) than in those without (black lines). Graph shows plots for individual mice (dotted) and ON or OFF averages (solid lines). * p<0.01 using multiple t-tests with Holm-Sidak multiple comparisons test and each timepoint analyzed individually without assuming a consistent SD. 
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Screening identified PAS638 response throughout the experiment. Graph shows switching of individual samples, with means. D) Colonies tested for function in vitro at day 159 showed tetrathionate specific switching.
